A phase II, randomized, open-label, multi-center study of weekly APG101+reirradiation versus reirradiation in the treatment of patients with recurrent glioblastoma
EUROPEAN JOURNAL OF CANCER(2013)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined